Cyclovirobuxine D pretreatment ameliorates septic heart injury through mitigation of ferroptosis

Myocardial dysfunction is a frequent complication in patients with severe sepsis. However, effective drugs for the prevention of myocardial dysfunction and the molecular mechanisms of the disease remain elusive. The present study demonstrated that Cyclovirobuxine D (CVB-D) could improve cardiac dysf...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jianxin, Guan, Peng, Chen, Yu, Xu, Meng, Wang, Na, Ji, Ensheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375449/
https://www.ncbi.nlm.nih.gov/pubmed/37522059
http://dx.doi.org/10.3892/etm.2023.12106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375449/
https://www.ncbi.nlm.nih.gov/pubmed/37522059
http://dx.doi.org/10.3892/etm.2023.12106

Ejemplares similares